Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2007
09/12/2007CN100336827C South China sea conus littertus linnaeus nervotoxin and its coding sequence and use
09/12/2007CN100336824C Recombinant protein efficient renaturation method
09/11/2007US7268276 Isolated polynucleotide encoding a transcription factor; suppressing endogenous expression of chalcone synthase, leucoanthocyanidin dioxygenase and phenylalanine ammonia lyase
09/11/2007US7268275 tcdB2 protein from Photorhabdus luminescens W-14
09/11/2007US7268272 Genetic control of plant growth and development
09/11/2007US7268271 Leaf cotyledon 1 (lec1); inducing asexual reproduction
09/11/2007US7268227 Posh nucleic acids, polypeptides and related methods
09/11/2007US7268224 Human glucocorticoid receptor 1A promoter and splice variants
09/11/2007US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis
09/11/2007US7268222 For use in therapeutic, diagnostic, and pharmacogenomic applications
09/11/2007US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones
09/11/2007US7268217 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative, nervous system and tumor disorders
09/11/2007US7268216 Chimeric avidin mutants
09/11/2007US7268215 Bioluminescent protein for use as tool in detection of monovalent cations derived from symplectoteuthis oualaniensis
09/11/2007US7268214 peptidomimetics; enhanced uptake via gastrointestinal systems
09/11/2007US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist
09/11/2007US7268212 Ligand of G protein-coupled receptor protein and DNA thereof
09/11/2007US7268209 Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient
09/11/2007US7268208 Solubility in aqueous solvents; for use in diagnosis, therapy
09/11/2007US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer
09/11/2007US7268120 Administering into a muscle of a mammal with cancer or metastasis thereof, a DNA plasmid comprising a polynucleotide which encodes interferon-alpha or an active fragment thereof, operably associated with a promoter
09/11/2007US7268117 Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
09/11/2007US7268116 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
09/11/2007US7268114 Protein and process for preparing the same
09/11/2007US7268113 Administering dosage complexed to blood
09/11/2007US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form
09/11/2007US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound
09/11/2007US7268109 Method for reducing pain
09/11/2007US7267985 Trangenic plant comprising regulatory elements and nucleotide sequences coding calmodulin like protein (CAMS) for use in controlling heterologous gene expression in plants
09/11/2007US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
09/11/2007US7267973 Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor
09/11/2007US7267965 Providing at least one Stabilizing Anti-Repression sequence to a nucleic acid encoding a protein enhances production (yield) of the protein by a host cell increases the proportion of host cells with acceptable expression levels, and/or increases stability of a gene expression level.
09/11/2007US7267964 Nucleotide sequences coding polypeptide for use as insecticide
09/11/2007US7267963 Modified plant viruses and methods of use thereof
09/11/2007US7267961 Reacting a sample of body fluid or tissue likely to contain antibodies with one or more protein sequences or peptides isolated from the E2, E6 and E7 early coding regions of HPV to form an antibody complex which is then detected
09/11/2007US7267960 Therapy for disease, infections; antiinflammatory agents; modulate cellular adhesion molecules; generation human dendritic cells; anticancer agents; bactericides
09/11/2007US7267959 For identifying compounds that effect binding between syntaxin protein and cytoplasmic nucleotide binding folds within receptor; solid phase synthesis; for treatment of diabetes; kits
09/11/2007US7267955 Method for detecting loss of wild-type p53
09/11/2007US7267944 Methods and compositions for combinatorial-based discovery of new multimeric molecules
09/11/2007US7267941 A viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity/immunogenicity, improve pharmacokinetics/bioavailability; envelope viruses
09/11/2007US7267940 HSV-2 type-specific immunoassays using glycoprotein G2 peptides
09/11/2007US7267825 Suitable for gene therapy
09/11/2007US7267823 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response
09/11/2007US7267822 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
09/11/2007US7267820 Detecting in body fluid an autoantibody to epitopes of muscle tyrosine kinase
09/11/2007US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3
09/11/2007US7267816 tolerant of freshwater/saltwater environments, capable of surviving freeze-drying process and remaining viable thereafter; polymerase chain reaction (PCR)
09/11/2007CA2310536C Erythropoietin derivatives
09/11/2007CA2293997C Male tissue-preferred regulatory region and method of using same
09/11/2007CA2269111C Genes encoding plant transcription factors
09/11/2007CA2247040C Purification method
09/11/2007CA2204357C Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
09/11/2007CA2196097C Secreted viral proteins useful for vaccines and diagnostics
09/11/2007CA2164498C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
09/11/2007CA2124690C Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
09/07/2007WO2007101273A2 Compositions related to the quantitative trait locus 6 (qtl6) in maize and methods of use
09/07/2007WO2007101002A2 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling
09/07/2007WO2007100807A2 Npc1l1 orthologues
09/07/2007WO2007100607A2 Immunogenic peptides and methods of use
09/07/2007WO2007100584A2 Antiviral agents and vaccines against influenza
09/07/2007WO2007100535A2 Oxyntomodulin derivatives
09/07/2007WO2007100358A2 Convergent synthesis of proteins by kinetically controlled ligation
09/07/2007WO2007100248A2 Adir related polymorphisms and applications thereof
09/07/2007WO2007100238A1 Disease resistant plants
09/07/2007WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule
09/07/2007WO2007100071A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction
09/07/2007WO2007100036A1 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium
09/07/2007WO2007099993A1 Antiviral peptide and antiviral agent
09/07/2007WO2007099921A1 PEPTIDE BINGING TO PILRα, POLYNUCLEOTIDE ENCODING THE SAME AND APPLICATION THEREOF
09/07/2007WO2007099885A1 Amino acid transporter gene and use of the same
09/07/2007WO2007099749A1 Gene encoding trehalose-6-phosphate phosphatase and use thereof
09/07/2007WO2007099722A1 Gene encoding protein responsible for flocculation property of yeast and use thereof
09/07/2007WO2007099695A1 Gene encoding protein responsible for flocculation property of yeast and use thereof
09/07/2007WO2007099694A1 Gene encoding protein responsible for flocculation property of yeast and use thereof
09/07/2007WO2007099446A2 Virosome-like vesicles comprising gp41-derived antigens
09/07/2007WO2007099387A1 Virosome-like vesicles comprising gp41-derived antigens
09/07/2007WO2007099096A1 Plants having increased yield and a method for making the same
09/07/2007WO2007098951A2 Method and apparatus for extraction of protein material from silkworm glands
09/07/2007WO2007098950A1 Master gene of arteriogenesis
09/07/2007WO2007098934A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
09/07/2007WO2007098717A2 Chimeric vaccine antigens against classical swine fever virus
09/07/2007WO2007098716A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them
09/07/2007WO2007098671A1 A method for preparing the primers for in vitro identifying mutations within larged vestibular aqueduct syndromic hearing loss pds gene and the use thereof
09/07/2007WO2007098611A1 Compositions for treatment of cancer
09/07/2007WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
09/07/2007WO2007098548A1 A molecule and chimeric molecules thereof
09/07/2007WO2007098547A1 A molecule and chimeric molecules thereof
09/07/2007WO2007084441A3 Novel fsh glycosylation variant d3n
09/07/2007WO2007082483B1 Medicament for treatment of tumor and the use thereof
09/07/2007WO2007077398A3 Gene promoters that can be used in plants
09/07/2007WO2007072032A3 Neisseria meningitidis vaccines and their use
09/07/2007WO2007068982A3 Detection of antibodies
09/07/2007WO2007063024A3 Keratin-binding effector molecules containing reactive dyes
09/07/2007WO2007060240A3 Method for demonstrating presence or absence of markers (eef1a1 or mark3 )associated with the presence and/or the chemosensitivity of tumors
09/07/2007WO2007055952A3 Process for producing stable hiv th-ctl peptides
09/07/2007WO2006020541A3 Methods for synthesizing polypeptides
09/07/2007WO2005094259A8 Leptin binding domain compositions and methods thereto
09/07/2007WO2005051313A3 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
09/07/2007WO2005011605A3 Combination therapies for multiple sclerosis
09/07/2007WO2004094455A8 Prophylactic and therapeutic benefits of new class of immune stimulating peptides